Pseudomized Health Data. Customer shall not upload, transmit, store or modify data that contains the information of any Person, including without limitation, data consisting of genomic information, whether or not Instrument Data, unless Customer has pseudomized such data and does not make available to Oxford information that permits such Pseudomized Data to be re-identified and, except with respect to contact information of Customer and its relevant personnel, does not make available personal data or personal information as defined by applicable law (e.g., HIPAA, EU Data Protection Directive (Directive 96/46/EC on the Protection of Individuals With Regard to the Processing of Personal Data and on the Free Movement of Such Data), Personal Data Protection Xxx 0000 (No. 26 of 2012), Privacy Xxx 0000 (Cth)). For example, Customer shall not provide the name, date of birth, address, social security number, government-issued identification number or any other information that could directly or indirectly identify the Person from whom any genomic or other information was derived.

Pseudomized Health Data. Customer shall not upload, transmit, store or modify data that contains the information of any Person, including without limitation, data consisting of genomic information, whether or not Instrument Data, unless Customer has pseudomized such data and does not make available to Oxford information that permits such Pseudomized Data to be re-identified and, except with respect to contact information of Customer and its relevant personnel, does not make available personal data, protected health information or personal information as defined by applicable law (e.g., HIPAA, the General Data Protection Regulation (EU) 2016/679, Personal Data Protection Act 2012 (No. 26 of 2012), Privacy Act 1988 (Cth), Privacy and Data Protection Act 2014 (Vic, Aus.) and the Health Records Act 2001 (Vic, Aus.), and the PRC Cyber Security Law and other PRC regulations concerning personal data or information protection). For example, Customer shall not provide the name, date of birth, address, social security number, government-issued identification number or any other information that could directly or indirectly identify the Person from whom any genomic or other information was derived.

See All (6)

See All (4)

Pseudomized Health Data. Customer shall not upload, transmit, store or modify data that contains the information of any Person, including without limitation, data consisting of genomic information, whether or not Instrument Data, unless Customer has pseudomized such data and does not make available to Oxford information that permits such Pseudomized Data to be re-identified and, except with respect to contact information of Customer and its relevant personnel, does not make available personal data or personal information as defined by applicable law (e.g., HIPAA, EU Data Protection Directive (Directive 96/46/EC on the Protection of Individuals With Regard to the Processing of Personal Data and on the Free Movement of Such Data), Personal Data Protection Act 2012 (No. 26 of 2012), Privacy Act 1988 (Cth) and the PRC Cyber Security Law and other PRC regulations concerning personal data or information protection). For example, Customer shall not provide the name, date of birth, address, social security number, government-issued identification number or any other information that could directly or indirectly identify the Person from whom any genomic or other information was derived.

Pseudomized Health Data. Customer shall not upload, transmit, store or modify data containing the information of any Person, including, without limitation, data consisting of genomic information, unless Customer has obtained (a) a written and signed authorization and consent to Customer’s transmission, storage and use of such information, (b) an advance written 4.6. 化名健康数据。客户不得上传、传输、储存或修改包含任何个人信息的数据，包括但不限于由基因组信息组成的数据，除非客户已获得 (a) 客户传输、储存和使用此类数据的书面签字授权和同意书，(b) 提前书面披露个人数据或个人信息的分享（根据适用法律定义）和 (c) 书面签字授权及同意由硬件、 MinKNOW 软件和/或网站收集此类信息采集 disclosure of sharing of personal data or personal information (as defined under applicable law) and (c) a written and signed authorization and opt-in to the collection by the Hardware, MinKNOW Software and/or Website of details regarding the location at which such information was acquired, the IP address from which Metrichor Interface is accessed, the ASIC ID and/or the Device ID. Customer shall not upload, transmit, store or modify data that contains the information of any Person, including without limitation, data consisting of genomic information, whether or not Instrument Data, unless Customer has pseudomized such data and does not make available to the Oxford Group information that permits such Pseudomized Data to be re-identified and, except with respect to contact information of Customer and its relevant personnel, does not make available personal data or personal information as defined by applicable law (e.g., HIPAA, EU Data Protection Directive (Directive 96/46/EC on the Protection of Individuals With Regard to the Processing of Personal Data and on the Free Movement of Such Data), Personal Data Protection Act 2012 (No. 26 of 2012), Privacy Act of 1988 (Cth) and the PRC Cyber Security Law and other PRC regulations concerning personal data or information protection). For example, Customer shall not provide the name, date of birth, address, social security number, government-issued identification number or any other information that could directly or indirectly identify the Person from whom any genomic or other information was derived. 位置、访问 Metrichor 接口的 IP 地址、ASIC ID 和/或设备 ID 等详细信息。客户不得上传、传输、储存或修改任何含有个人信息的数据，包括但不限于含有基因信息的数据，无论是否是仪器数据，除非客户对此类数据进行化名处理并不向 Oxford 集团提供可让此类化名数据泄露身份的信息，但不含客户以及相关人员的联系信息，不提供适用法律定义的任何个人数据或个人信息（例如，HIPAA；《欧盟数据保护指令 - 关于个人数据处理和自由流动的个人保护》指令 96/46/EC；《2012 年个人数据保护法案 - 2012 年第 26 号》；《1988 年隐私法 (Cth)》以及中国《网络安全法》和其他有关个人数据或信息保护的中国法规）。例如，客户不得提供姓名、出生日期、地址、社会保障号码、政府签发的身份证件号码或任何其他可直接或间接识别个人身份的信息（从此人推断出任何基因组或其他信息）。

Related to Pseudomized Health Data

Behavioral Health Services – Mental Health and Substance Use Disorder Inpatient - Unlimited days at a general hospital or a specialty hospital including detoxification or residential/rehabilitation per plan year. Preauthorization may be required for services received from a non-network provider. 0% - After deductible 40% - After deductible Outpatient or intermediate careservices* - See Covered Healthcare Services: Behavioral Health Section for details about partial hospital program, intensive outpatient program, adult intensive services, and child and family intensive treatment. Preauthorization may be required for services received from a non-network provider. 0% - After deductible 40% - After deductible Office visits - See Office Visits section below for Behavioral Health services provided by a PCP or specialist. Psychological Testing 0% - After deductible 40% - After deductible Medication-assisted treatment - whenrenderedby a mental health or substance use disorder provider. 0% - After deductible 40% - After deductible Methadone maintenance treatment - one copayment per seven-day period of treatment. 0% - After deductible 40% - After deductible Outpatient - Benefit is limited to 18 weeks or 36 visits (whichever occurs first) per coveredepisode. 0% - After deductible 40% - After deductible In a physician's office - limited to 12 visits per plan year. 0% - After deductible 40% - After deductible Emergency room - When services are due to accidental injury to sound natural teeth. 0% - After deductible The level of coverage is the same as network provider. In a physician’s/dentist’s office - When services are due to accidental injury to sound natural teeth. 0% - After deductible 40% - After deductible Services connected to dental care when performed in an outpatient facility * 0% - After deductible 40% - After deductible Inpatient/outpatient/in your home 0% - After deductible 40% - After deductible (*) Preauthorization may be required for this service. Please see Preauthorization in Section 5 for more information. You Pay You Pay Outpatient durable medical equipment* - Must be provided by a licensed medical supply provider. 20% - After deductible 40% - After deductible Outpatient medical supplies* - Must be provided by a licensed medical supply provider. 20% - After deductible 40% - After deductible Outpatient diabetic supplies/equipment purchasedat licensed medical supply provider (other than a pharmacy). See the Summary of Pharmacy Benefits for supplies purchased at a pharmacy. 20% - After deductible 40% - After deductible Outpatient prosthesis* - Must be provided by a licensed medical supply provider. 20% - After deductible 40% - After deductible Enteral formula delivered through a feeding tube. Must be sole source of nutrition. 20% - After deductible 40% - After deductible Enteral formula or food taken orally * 20% - After deductible The level of coverage is the same as network provider. Hair prosthesis (wigs) - The benefit limit is $350 per hair prosthesis (wig) when worn for hair loss suffered as a result of cancer treatment. 20% - After deductible The level of coverage is the same as network provider. Coverage provided for members from birth to 36 months. The provider must be certified as an EIS provider by the Rhode Island Department of Human Services. 0% - After deductible The level of coverage is the same as network provider. Asthma management 0% - After deductible 40% - After deductible Hospital emergency room 0% - After deductible The level of coverage is the same as network provider.
Service Animals Humber Residence acknowledges the rights of persons with disabilities to retain their service animal while living in Residence. In order to preserve the health and safety of all people and animals living or working in the Residence environment, the Resident will notify the Residence Office that they require a service animal and will provide documentation as outlined in the Accessibility for Ontarians with Disabilities Act confirming that the Resident requires the service animal. The Resident will also complete a Service Animal Agreement with the Residence Manager or designate, and agrees to adhere to the requirements within it.
SHOP DRAWINGS, PRODUCT DATA AND SAMPLES 4.12.1 Shop Drawings are drawings, diagrams, schedules and other, data specially prepared for the Work by the Contractor or any Subcontractor, manufacturer, supplier or distributor to illustrate some portion of the Work. 4.12.2 Product Data are illustrations, standard schedules, performance charts, instructions, brochures, diagrams and other information furnished by the Contractor to illustrate a material, product or system for some portion of the Work. 4.12.3 Samples are physical examples which illustrate materials, equipment or workmanship and establish standards by which the Work will be judged. 4.12.4 The Contractor shall review, approve and submit, with reasonable promptness and in such sequence as to cause no delay in the Work or in the work of the State or any separate contractor, all Shop Drawings, Product Data and Samples required by the Contract Documents. 4.12.5 By approving and submitting Shop Drawings, Product Data and Samples, the Contractor represents that he / she has determined and verified all materials, field measurements, and field construction criteria related thereto, or will do so, and that he / she has checked and coordinated the information contained within such submittals with the requirements of the Work and of the Contract Documents. 4.12.6 The Contractor shall not be relieved of responsibility for any deviation from the requirements of the Contract Documents by the Architect's approval of Shop Drawings, Product Data or Samples under Subparagraph 2.2.7 of these General Conditions unless the Contractor has specifically informed the Architect and the State in writing of such deviation at the time of sub- mission and the Architect and the State has given written approval to the specific deviation. The Contractor shall not be relieved from responsibility for errors or omissions in the Shop Drawings, Product Data or Samples by the Architect's approval thereof. 4.12.7 The Contractor shall direct specific attention, in writing or on resubmitted Shop Drawings, Product Data or Samples, to revisions other than those requested by the Architect on previous submittals. 4.12.8 No portion of the Work requiring submission of a Shop Drawing, Product Data or Sample shall be commenced until the submittal has been approved by the Architect as provided in Subparagraph 2.2.7 of these General Conditions. All such portions of the Work shall be in accordance with approved submittals.
Random Drug Testing All employees covered by this Agreement shall be subject to random drug testing in accordance with Appendix D.
Information Technology Accessibility Standards Any information technology related products or services purchased, used or maintained through this Grant must be compatible with the principles and goals contained in the Electronic and Information Technology Accessibility Standards adopted by the Architectural and Transportation Barriers Compliance Board under Section 508 of the federal Rehabilitation Act of 1973 (29 U.S.C. §794d), as amended. The federal Electronic and Information Technology Accessibility Standards can be found at: xxxx://xxx.xxxxxx-xxxxx.xxx/508.htm.
Infectious Diseases The Employer and the Union desire to arrest the spread of infectious diseases in the nursing home. To achieve this objective, the Joint Health and Safety Committee may review and offer input into infection control programs and protocols including surveillance, outbreak control, isolation, precautions, worker education and training, and personal protective equipment. The Employer will provide training and ongoing education in communicable disease recognition, use of personal protective equipment, decontamination of equipment, and disposal of hazardous waste.
Animals The Hirer shall ensure that no animals (including birds) except guide dogs are brought into the premises, other than for a special event agreed to by the Village Hall. No animals whatsoever are to enter the kitchen at any time.
ACCESS TO PROTECTED HEALTH INFORMATION 7.1 To the extent Covered Entity determines that Protected Health Information is maintained by Business Associate or its agents or Subcontractors in a Designated Record Set, Business Associate shall, within two (2) business days after receipt of a request from Covered Entity, make the Protected Health Information specified by Covered Entity available to the Individual(s) identified by Covered Entity as being entitled to access and shall provide such Individuals(s) or other person(s) designated by Covered Entity with a copy the specified Protected Health Information, in order for Covered Entity to meet the requirements of 45 C.F.R. § 164.524. 7.2 If any Individual requests access to Protected Health Information directly from Business Associate or its agents or Subcontractors, Business Associate shall notify Covered Entity in writing within two (2) days of the receipt of the request. Whether access shall be provided or denied shall be determined by Covered Entity. 7.3 To the extent that Business Associate maintains Protected Health Information that is subject to access as set forth above in one or more Designated Record Sets electronically and if the Individual requests an electronic copy of such information, Business Associate shall provide the Individual with access to the Protected Health Information in the electronic form and format requested by the Individual, if it is readily producible in such form and format; or, if not, in a readable electronic form and format as agreed to by Covered Entity and the Individual.
Protocols Each party hereby agrees that the inclusion of additional protocols may be required to make this Agreement specific. All such protocols shall be negotiated, determined and agreed upon by both parties hereto.
Clinical Data and Regulatory Compliance The preclinical tests and clinical trials, and other studies (collectively, “studies”) that are described in, or the results of which are referred to in, the Registration Statement or the Prospectus were and, if still pending, are being conducted in all material respects in accordance with the protocols, procedures and controls designed and approved for such studies and with standard medical and scientific research procedures; each description of the results of such studies is accurate and complete in all material respects and fairly presents the data derived from such studies, and the Company and its subsidiaries have no knowledge of any other studies the results of which are inconsistent with, or otherwise call into question, the results described or referred to in the Registration Statement or the Prospectus; the Company and its subsidiaries have made all such filings and obtained all such approvals as may be required by the Food and Drug Administration of the U.S. Department of Health and Human Services or any committee thereof or from any other U.S. or foreign government or drug or medical device regulatory agency, or health care facility Institutional Review Board (collectively, the “Regulatory Agencies”); neither the Company nor any of its subsidiaries has received any notice of, or correspondence from, any Regulatory Agency requiring the termination, suspension or modification of any clinical trials that are described or referred to in the Registration Statement or the Prospectus; and the Company and its subsidiaries have each operated and currently are in compliance in all material respects with all applicable rules, regulations and policies of the Regulatory Agencies.

Pseudomized Health Data Sample Clauses

Filter & Search

Related Clauses

Parent Clauses

Related to Pseudomized Health Data